Biomerica BMRA
NASDAQ BMRA
$2.16 -0.09 (-4.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biomerica (BMRA) Gains from Sales and Divestitures (2014 - 2015)

Updated

Biomerica's Gains from Sales and Divestitures was -$53,000 in FY2022 (year ended May 31, 2022).

Analysis

Biomerica (BMRA) Gains from Sales and Divestitures (2014 - 2015) Analysis & Trends

From FY2011 onward, Biomerica has reported Gains from Sales and Divestitures for 5 fiscal years.

  • The FY2022 figure marks the highest annual Gains from Sales and Divestitures in data going back to FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Biomerica 6.90 Mn -1.34 Mn -71,000.00
Historic Data

Historic Data

Download Data
DateValue
May 31, 2015 -1,330.00
Aug 31, 2014 665.00
API Access

Biomerica Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=BMRA&period=max&api_key=YOUR_API_KEY